CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's Operating Income Growth by Quarter and Year

Atara Biotherapeutics,'s Operating Income results by quarter and year




ATRA Operating Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - -35.80 -18.75 -21.77
III Quarter September - -31.66 -25.94 -12.26
II Quarter June -52.62 -27.91 -19.49 -15.11
I Quarter March -42.45 -26.16 -17.06 -9.31
FY   -95.07 -121.53 -81.24 -58.45



ATRA Operating Income second quarter 2018 Y/Y Growth Comment
Atara Biotherapeutics, Inc. in the second quarter recorded Operating Loss of $ -52.62 millions.

According to the results reported in the second quarter, Atara Biotherapeutics, Inc. achieved the best Operating Income growth in Biotechnology & Drugs industry. While Atara Biotherapeutics, Inc.' s Operating Income no change of % ranks overall at the positon no. in the second quarter.

Explain Operating Income growth


ATRA Operating Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics,'s second quarter 2018 Operating Income $ -52.62 millions ATRA's Income Statement
Atara Biotherapeutics,'s second quarter 2017 Operating Income $ -27.91 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Operating Income Growth >>


ATRA Operating Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income second quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income second quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018
You need to upgrade your Flash Player

Atara Biotherapeutics,'s Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q Operating Income Comment
Current results of -52.62 millions by Atara Biotherapeutics, Inc. come out even worse if you take a look at -42.45 millions Operating Loss in the first quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Operating Income growth. While Atara Biotherapeutics,'s Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q Operating Income Comment
Recent accomplishment of -52.62 millions by Atara Biotherapeutics, Inc. appear even more unfavourable if you take a look at Operating Loss -42.45 millions in the previous quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Operating Income growth. While Atara Biotherapeutics,'s Operating Income growth quarter on quarter, overall rank is .


Atara Biotherapeutics,'s 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
12 Months Ending
(Jun 30 2017)
Cumulative Operating Income 12 Months Ending $ -162.54 $ -137.82 $ -121.53 $ -104.48 $ -98.77
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months Operating Loss of $ -163 millions in the Jun 30 2018 period.
The results are worsening as the cumulative Operating Loss is becoming larger from $ -137.82 millions for the period from Mar 31 2018 to Jun 30 2017 and $ -42.45 millions for the twelve months ending in the quarter a year ago Jada Evans told.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months Operating Loss of $ -163 millions in the Jun 30 2018 period.
The business is detiriorating as the cumulative Operating Loss is becoming larger from $ -137.82 millions in the twelve months ending a quarter before and $ -42.45 millions for the twelve months ending in the quarter Jun 30 2017 Jada Evans mentioned.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


You need to upgrade your Flash Player




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ATRA's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ATRA's Competitors
Operating Income Growth for Atara Biotherapeutics,'s Suppliers
Operating Income Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Jun 30 2018 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Jun 30 2018
Biotelemetry, Inc.  153.49 %$ 153.487 millions
United Therapeutics Corp  145.65 %$ 145.650 millions
Lemaitre Vascular Inc  108.47 %$ 108.472 millions
Shire Plc  107.97 %$ 107.966 millions
Abbott Laboratories  106.56 %$ 106.557 millions
Meridian Bioscience Inc  102.95 %$ 102.951 millions
Hill-rom Holdings, Inc.  94.31 %$ 94.307 millions
Alr Technologies Inc.  94.19 %$ 94.195 millions
Tactile Systems Technology Inc  79.59 %$ 79.589 millions
Boston Scientific Corporation  74.22 %$ 74.222 millions
Inogen Inc  65.01 %$ 65.011 millions
Magellan Health Inc  64.32 %$ 64.320 millions
Integra Lifesciences Holdings Corp  62.70 %$ 62.696 millions
Corcept Therapeutics Inc  61.27 %$ 61.266 millions
Jrsis Health Care Corp  55.01 %$ 55.010 millions
Steadymed Ltd.  51.88 %$ 51.875 millions
Align Technology Inc  46.81 %$ 46.814 millions
Resmed Inc  45.65 %$ 45.652 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

STAK's Profile

Stock Price

STAK's Financials

Business Description

Fundamentals

Charts & Quotes

STAK's News

Suppliers

STAK's Competitors

Customers & Markets

Economic Indicators

STAK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071